Author Correction: miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2 (Nature, (2014), 512, 7515, (431-435), 10.1038/nature13375);MiR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2

Nature

Volumn 512, Issue 7515, 2014, Pages 431-435

  Krzeszinski, Jing Y ^a   Wei, Wei ^a   Huynh, Hoangdinh ^a   Jin, Zixue ^a   Wang, Xunde ^a   Chang, Tsung Cheng ^b   Xie, Xian Jin ^b,c   He, Lin ^d   Mangala, Lingegowda S ^e   Lopez Berestein, Gabriel ^e   Sood, Anil K ^e   Mendell, Joshua T ^b,c   Wan, Yihong ^a,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 34A; OSTEOCLAST DIFFERENTIATION FACTOR; TRANSFORMING GROWTH FACTOR BETA2;

BONE; HETEROZYGOSITY; RNA; RODENT; SKELETON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MASS; BONE METASTASIS; BREAST CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; OVARIECTOMY-INDUCED OSTEOPOROSIS; PRIORITY JOURNAL; SEQUENCE ALIGNMENT; SKIN CANCER; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; BASE SEQUENCE; BONE NEOPLASMS; BONE RESORPTION; CELL DIFFERENTIATION; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FEMALE; GENE DELETION; HOMEODOMAIN PROTEINS; HUMANS; MALE; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, TRANSGENIC; MICRORNAS; NEOPLASM TRANSPLANTATION; ORGAN SIZE; OSTEOCLASTS; OSTEOPOROSIS; OVARIECTOMY; REPRESSOR PROTEINS; SKIN NEOPLASMS; TRANSGENES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84907406375     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/s41586-019-1266-4     Document Type: Erratum

References (31)

1. Coleman, R. E. Bone cancer in 2011: prevention and treatment of bone metastases. Nature Rev. Clin. Oncol. 9, 76-78 (2012).
2. Ell, B. & Kang, Y. SnapShot: bone metastasis. Cell 151, 690 (2012).
3. Novack, D. V. & Teitelbaum, S. L. The osteoclast: friend or foe? Annu. Rev. Pathol. 3, 457-484 (2008).
4. Chivukula, R. R. & Mendell, J. T. Circular reasoning: microRNAs and cell-cycle control. Trends Biochem. Sci. 33, 474-481 (2008).
5. Ventura, A. & Jacks, T. MicroRNAs and cancer: short RNAs go a long way. Cell 136, 586-591 (2009).
6. Kasinski, A. L. & Slack, F. J. Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nature Rev. Cancer 11, 849-864 (2011).
7. Wan, Y., Chong, L. W. & Evans, R. M. PPAR-c regulates osteoclastogenesis in mice. Nature Med. 13, 1496-1503 (2007).
8. Wei, W. et al. PGC1b mediates PPARc activation of osteoclastogenesis and rosiglitazone-induced bone loss. Cell Metab. 11, 503-516 (2010).
9. Choi, Y. J. et al. miR-34 miRNAs provide a barrier for somatic cell reprogramming. Nature Cell Biol. 13, 1353-1360 (2011).
10. Concepcion, C. P. et al. Intact p53-dependent responses in miR-34-deficient mice. PLoS Genet. 8, e1002797 (2012).
11. Bae, Y. et al. miRNA-34c regulates Notch signaling during bone development. Hum. Mol. Genet. 21, 2991-3000 (2012).
12. Wei, J. et al. miR-34s inhibit osteoblast proliferation and differentiation in the mouse by targeting SATB2. J. Cell Biol. 197, 509-521 (2012).
13. Ell, B. et al. Tumor-induced osteoclast miRNA changes as regulators and biomarkers of osteolytic bone metastasis. Cancer Cell 24, 542-556 (2013).
14. Yamakuchi, M., Ferlito, M. & Lowenstein, C. J. miR-34a repression of SIRT1 regulates apoptosis. Proc. Natl Acad. Sci. USA 105, 13421-13426 (2008).
15. Lefort, K. et al. A miR-34a-SIRT6 axis in the squamous cell differentiation network. EMBO J. 32, 2248-2263 (2013).
16. Boon, R. A. et al. MicroRNA-34a regulates cardiac ageing and function. Nature 495, 107-110 (2013).
17. Lodygin, D. et al. Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 7, 2591-2600 (2008).
18. Hermeking, H. p53 enters the microRNA world. Cancer Cell 12, 414-418 (2007).
19. Liu, C. et al. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nature Med. 17, 211-215 (2011).
20. Fukuda, T. et al. Generation of a mouse with conditionally activated signaling through the BMP receptor, ALK2. Genesis 44, 159-167 (2006).
21. Wei, W. et al. Osteoclast progenitors reside in the peroxisome proliferator-activated receptor gamma-expressing bone marrow cell population. Mol. Cell. Biol. 31, 4692-4705 (2011).
22. Clausen, B. E., Burkhardt, C., Reith, W., Renkawitz, R. & Forster, I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8, 265-277 (1999).
23. Nakamura, T. et al. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell 130, 811-823 (2007).
24. Maes, C. et al. Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels. Dev. Cell 19, 329-344 (2010).
25. Powers, S. E. et al. Tgif1 and Tgif2 regulate Nodal signaling and are required for gastrulation. Development 137, 249-259 (2010).
26. Lu, C. et al. Regulation of tumor angiogenesis by EZH2. Cancer Cell 18, 185-197 (2010).
27. Wei, W. et al. Biphasic and dosage-dependent regulation of osteoclastogenesis by b-catenin. Mol. Cell. Biol. 31, 4706-4719 (2011).
28. Lu, X. et al. ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. Genes Dev. 23, 1882-1894 (2009).
29. Kang, Y. et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3, 537-549 (2003).
30. Uluckan, O. et al. APT102, a novel adpase, cooperates with aspirin to disrupt bone metastasis in mice. J. Cell. Biochem. 104, 1311-1323 (2008).
31. Chang, T. C. et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nature Genet. 40, 43-50 (2008).